{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Mahwah",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA205994"
        ],
        "brand_name": [
          "SAXAGLIPTIN"
        ],
        "generic_name": [
          "SAXAGLIPTIN"
        ],
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "product_ndc": [
          "68462-726",
          "68462-727"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "SAXAGLIPTIN HYDROCHLORIDE"
        ],
        "rxcui": [
          "858036",
          "858042"
        ],
        "spl_id": [
          "4d1a25c6-4ffc-4714-98a9-c4dcb2049d6d"
        ],
        "spl_set_id": [
          "e286ffd4-c598-47fb-af06-2e15f7e6f99f"
        ],
        "package_ndc": [
          "68462-726-30",
          "68462-726-90",
          "68462-726-05",
          "68462-727-30",
          "68462-727-90",
          "68462-727-05",
          "68462-727-14"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "Z8J84YIX6L"
        ]
      },
      "product_type": "Drugs",
      "event_id": "96474",
      "recalling_firm": "Glenmark Pharmaceuticals Inc., USA",
      "address_1": "750 Corporate Dr",
      "address_2": "N/A",
      "postal_code": "07430-2009",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "U.S. Nationwide",
      "recall_number": "D-0345-2025",
      "product_description": "Saxagliptin Tablets, USP, 2.5mg, a). 30-count bottle (NDC# 68462-726-30), b).90-count bottle(NDC# 68462-726-90), Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.",
      "product_quantity": "N/A",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20250313",
      "center_classification_date": "20250408",
      "report_date": "20250416",
      "code_info": "30-Count Bottle Lots:   17241788, exp. date Sep-26 17241821, exp. date Sep-26 17241822, exp. date Sep-26   90-Count Bottle Lot:  17241822, exp. date Sept 26"
    }
  ]
}